Free cash flow slid from $18.4M in 2024Q4 to roughly break-even (-$32.0K) in 2026Q3 as the OCF-to-NI ratio collapsed from 11.98 to 0.36, while $79.9M of cumulative buybacks outpaced the $64.8M of ten-quarter free cash flow.
Franklin Covey Co. (FC) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Aug'26 | Aug'25 | Aug'24 | Aug'23 | Aug'22 | Aug'21 | Aug'20 | Aug'19 | Aug'18 | Aug'17 | Aug'16 | Aug'15 | Aug'14 | Aug'13 | Aug'12 | Aug'11 | Aug'10 | Aug'09 | Aug'08 | Aug'07 | Aug'06 | Aug'05 | Aug'04 | Aug'03 | Aug'02 | Aug'01 | Aug'00 | Aug'99 | Aug'98 | Aug'97 |
|---|
| Cash from Operations | 21.59M | 28.98M | 60.26M | 35.74M | 52.25M | 46.18M | 27.56M | 30.45M | 16.86M | 17.36M | 32.66M | 26.19M | 18.12M | 15.53M | 15.56M | 15.64M | 7.02M | 5.28M | 7.83M | 13.36M | 17.01M | 22.26M | 11.12M | 5.8M | -7.02M | 35.72M | 50.62M | 36M | 74.1M | 45.7M |
| Operating CF Margin % | 8.26% | 10.85% | 20.98% | 12.74% | 19.88% | 20.6% | 13.89% | 13.51% | 8.04% | 9.37% | 16.33% | 12.47% | 8.83% | 8.13% | 9.13% | 9.73% | 5.13% | 4.06% | 3.01% | 4.7% | 6.1% | 7.85% | 4.04% | 1.89% | -2.11% | 6.8% | 8.65% | 6.49% | 13.56% | 10.55% |
| Operating CF Growth % | -25.5% | -51.91% | 68.61% | -31.61% | 13.16% | 67.53% | -9.49% | 80.61% | -2.86% | -46.86% | 24.72% | 44.5% | 16.72% | -0.22% | -0.52% | 122.71% | 32.98% | -32.52% | -41.4% | -21.47% | -23.6% | 100.22% | 91.64% | 182.64% | -119.66% | -29.44% | 40.62% | -51.42% | 62.14% | 0.66% |
| Net Income | 4.92M | 3.07M | 23.4M | 17.78M | 18.43M | 13.62M | -9.44M | -1.02M | -5.89M | -7.17M | 7.02M | 11.12M | 18.07M | 14.32M | 7.84M | 4.81M | -518K | -10.83M | 5.85M | 7.63M | 28.57M | 10.19M | -10.15M | -45.25M | -100.58M | -11.08M | -4.41M | -8.8M | 42.1M | 38.9M |
| Depreciation & Amortization | 8.02M | 12.9M | 12.09M | 12.53M | 14.44M | 15.64M | 11.6M | 11.36M | 10.53M | 11.19M | 6.94M | 7.88M | 7.33M | 6.13M | 5.7M | 7.11M | 7.43M | 8.04M | 9.53M | 10.03M | 10.29M | 14.73M | 17.81M | 32.94M | 42.05M | 47.87M | 48.51M | 43.5M | 38.6M | 23.6M |
| Stock-Based Compensation | 6.56M | 5.8M | 10.14M | 12.52M | 8.29M | 8.62M | -573K | 4.79M | 2.85M | 3.66M | 3.12M | 2.54M | 3.53M | 3.59M | 3.83M | 2.79M | 1.1M | 468K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | -423K | 1.47M | 1.89M | 4.75M | 121K | -9.79M | 9.09M | -1.05M | -2.54M | -5.59M | 1.85M | 3.67M | -679K | -1.74M | 2.71M | 2.09M | 2.41M | -5.48M | 4.15M | 5.27M | -15.44M | -410K | 623K | -1.32M | -16.15M | 637K | 1.56M | -10.5M | 600K | 0 |
| Other Non-Cash Items | 2.51M | 610K | 928K | 7K | 68K | 193K | 3.9M | 6.29M | 6.29M | -2.1M | 5.46M | 5.29M | -1.23M | 971K | 1.85M | 1.74M | 1.07M | 8.2M | 1.22M | 1.39M | 843K | -402K | 0 | 3.76M | 47.76M | 147K | -8.06M | 100K | -100K | 900K |
| Working Capital Changes | 0 | 5.13M | 11.81M | -11.85M | 10.91M | 17.89M | 12.98M | 10.09M | 5.62M | 17.38M | 8.28M | -4.29M | -8.89M | -7.74M | -6.37M | -2.89M | -4.46M | 4.89M | -6.32M | -9.72M | -7.26M | -1.84M | 2.83M | 15.68M | 19.9M | -1.85M | 12.46M | -6.1M | -7M | -17.7M |
| Change in Receivables | 0 | 17.46M | -3.76M | -9.45M | -2.41M | -14.27M | 17.14M | -1.77M | -5.68M | 164K | -576K | -4.36M | -9.55M | -15.17M | -5.81M | -1.29M | -7.6M | 5.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | -1.16M | 228K | -692K | -1.05M | 463K | 552K | -260K | 157K | 1.58M | -908K | 2.24M | -2.14M | -358K | 96K | 382K | 606K | 2.17M | 2.85M | -2.43M | -845K | 2.81M | 13.26M | 2.34M | 3.41M | 8.3M | 3.94M | -12M | 8.1M | -1.1M |
| Change in Payables | 0 | -5.77M | 403K | -9.54M | 4.36M | 14.37M | -5.46M | 2.93M | 1.75M | 676K | 2.26M | -3.25M | 3.65M | 6.17M | -998K | -2.09M | 1.83M | -1.23M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -12.38M | -16.89M | -11.31M | -13.55M | -5.33M | -14.31M | -11.87M | -6.87M | -10.63M | -21.68M | -6.23M | -4.87M | -17.42M | -9.58M | -4.39M | -10.83M | -2M | -3.2M | 18.52M | -11.48M | -8.27M | 4.87M | -2.41M | -2.77M | 152.51M | -16.36M | -38.94M | -40.7M | -43.8M | -80M |
| Capital Expenditures | -5.38M | -8.25M | -3.69M | -4.51M | -3.18M | -1.6M | -9.27M | -6.84M | -9.53M | -14.4M | -6.23M | -4.61M | -11.26M | -5.4M | -4.39M | -5.42M | -1.38M | -2.27M | -8.21M | -14.23M | -8.36M | -4.18M | -3.97M | -4.2M | -10.59M | -27.03M | -24.52M | -42M | -56M | -20.2M |
| CapEx % of Revenue | 2.06% | 3.09% | 1.29% | 1.61% | 1.21% | 0.71% | 4.67% | 3.04% | 4.54% | 7.77% | 3.11% | 2.2% | 5.49% | 2.83% | 2.58% | 3.37% | 1.01% | 1.75% | 3.16% | 5.01% | 3% | 1.47% | 1.44% | 1.37% | 3.18% | 5.14% | 4.19% | 7.57% | 10.25% | 4.66% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -10.21M | 0 | -32K | -1.11M | -7.27M | 0 | -262K | -6.17M | -4.18M | 0 | -5.41M | -3.26M | -956K | 1.18M | 150K | 0 | 500K | 0 | -1M | 0 | -4.43M | -21.44M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -7.01M | -8.63M | -7.62M | -9.04M | -2.15M | -2.5M | -2.6M | 0 | -3M | -7.22M | -2.24M | -2.17M | -7.79M | -3.22M | -2.11M | 0 | 2.64M | 28K | 25.55M | 2.6M | 93K | -2.18M | 1.56M | 2.43M | 163.1M | 15.1M | 7.03M | 1.3M | 12.2M | -59.8M |
| Cash from Financing | 0 | -28.78M | -38.66M | -44.18M | -32.67M | -11.48M | -16.56M | -5.93M | -4.68M | 3.13M | -32.53M | -14.9M | -2.44M | -3.83M | -3.19M | -5.09M | -3.62M | -16.25M | -16.16M | -26.38M | -29.9M | -5.96M | -8.87M | -8.81M | -113.87M | -25M | -18M | 2.3M | -21.6M | 30.7M |
| Debt Issued (Net) | 0 | -3.95M | -5.83M | -9.43M | -8.72M | -7.6M | -2.33M | -6.24M | -1.16M | 7.71M | 12.59M | -1.3M | -1.16M | -3.73M | -3.19M | -5.21M | -4.01M | 11.74M | -16.62M | 15.39M | -1.11M | 33.05M | -102K | -185K | -105.04M | -12.51M | -16.71M | -41.8M | 31.9M | 64.1M |
| Equity Issued (Net) | 0 | -24.83M | -29.28M | -34.02M | -22.51M | -1.9M | -12.93M | 963K | -1.2M | -4.75M | -42.91M | -13.74M | -3.77M | -1.01M | -5K | 110K | 238K | -27.99M | 462K | -39.58M | -24.74M | -29.98M | -28K | 105K | 429K | -6.41M | 4.68M | 44.1M | -53.4M | -33.4M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.21M | -4.88M | -9.02M | -8.73M | -8.73M | -4.37M | -6.08M | -5.98M | 0 | 0 | 0 |
| Share Repurchases | 0 | -26.37M | -30.75M | -35.55M | -23.85M | -2.97M | -13.97M | -12K | -2.01M | -5.43M | -43.59M | -14.43M | -4.38M | -1.31M | -440K | -218K | -50K | -28.27M | 0 | -39.97M | -25.17M | -30.09M | -182K | -131K | -73K | -7.46M | -5.48M | -32.7M | -57M | -36.4M |
| Other Financing | 0 | 0 | -3.54M | -736K | -1.43M | -1.98M | -1.3M | -653K | -2.32M | 168K | -2.22M | 137K | 2.48M | 903K | 0 | 0 | 159K | 0 | 0 | 27K | 833K | 0 | 0 | 0 | -4.89M | 0 | 0 | 0 | -100K | 0 |
| Net Change in Cash | 0 | -16.96M | 10.43M | -22.29M | 13.1M | 20.28M | -562K | 17.55M | 1.23M | -1.53M | -5.78M | 5.75M | -1.81M | 1.28M | 8M | -468K | 1.8M | -14.22M | 9.78M | -24.46M | -21.1M | 20.52M | -12K | -5.13M | 32.19M | -6.38M | -5.54M | -1M | 7.4M | 30.7M |
| Free Cash Flow | 16.21M | 12.09M | 56.56M | 22.19M | 46.92M | 42.07M | 18.3M | 23.61M | 7.33M | 2.95M | 26.44M | 21.58M | 6.87M | 10.13M | 11.17M | 10.22M | 5.64M | 3.01M | -378K | -868K | 8.65M | 18.08M | 7.15M | 1.6M | -17.61M | 8.69M | 26.1M | -6M | 18.1M | 25.5M |
| FCF Margin % | 6.2% | 4.53% | 19.69% | 7.91% | 17.85% | 18.77% | 9.22% | 10.48% | 3.5% | 1.59% | 13.21% | 10.28% | 3.35% | 5.31% | 6.55% | 6.36% | 4.12% | 2.31% | -0.15% | -0.31% | 3.1% | 6.38% | 2.6% | 0.52% | -5.29% | 1.65% | 4.46% | -1.08% | 3.31% | 5.89% |
| FCF Growth % | 34.11% | -78.63% | 154.93% | -52.71% | 11.53% | 129.92% | -22.5% | 221.9% | 148.31% | -88.83% | 22.51% | 214.23% | -32.21% | -9.31% | 9.3% | 81.21% | 87.56% | 895.5% | 56.45% | -110.04% | -52.17% | 152.94% | 346.53% | 109.09% | -302.63% | -66.69% | 535% | -133.15% | -29.02% | -1.54% |
| FCF per Share | 1.38 | 0.93 | 4.20 | 1.55 | 3.22 | 2.97 | 1.32 | 1.69 | 0.53 | 0.21 | 1.75 | 1.28 | 0.41 | 0.56 | 0.61 | 0.58 | 0.42 | 0.22 | -0.02 | -0.04 | 0.42 | 0.91 | 0.36 | 0.08 | -0.89 | 0.43 | 1.28 | -0.29 | 0.73 | 1.15 |
| FCF Conversion (FCF/Net Income) | 4.38x | 9.44x | 2.57x | 2.01x | 2.84x | 3.39x | -2.92x | -29.77x | -2.86x | -2.42x | 4.66x | 2.36x | 1.00x | 1.08x | 1.98x | 3.25x | -13.56x | -0.49x | 1.34x | 1.75x | 0.60x | 2.19x | -1.10x | -0.13x | 0.07x | -3.22x | -11.48x | -4.09x | 1.85x | 1.17x |
| Interest Paid | 0 | 496K | 1.11M | 1.5M | 1.66M | 2.07M | 2.28M | 2.39M | 2.65M | 2.31M | 2.23M | -2.13M | -2.24M | -2.32M | -2.47M | -2.7M | 2.86M | 3.03M | 3.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 7.69M | 4.21M | 3.31M | 3.21M | 1.77M | 2.06M | 1.78M | 2.51M | 2.56M | 3.41M | -2.38M | -6.32M | -4M | -2.33M | -1.82M | 428K | 2.79M | 3.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying FC stock.
Franklin Covey Co. (FC) generated $21.6M in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.
Franklin Covey Co. (FC) generated $16.2M in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Franklin Covey Co. (FC) spent $5.4M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
Key Metrics
Top Statement Risk
Buybacks outpacing declining cash generation
Metrics are mathematically derived from official filings.
Cash Conversion Quality Rapidly Weakening
Across the trailing four quarters, operating cash flow of $27.4M vastly exceeded $2.2M of net income, yet the OCF-to-NI ratio collapsed from 11.98 in 2025Q1 to 0.36 in 2026Q3, and based on Franklin Covey's reported cash flow statements, the trend suggests earnings support increasingly rests on non-cash add-backs rather than collection strength.
The very wide gap between cumulative net income and operating cash flow is largely explained by roughly $2.0-2.2M of quarterly depreciation plus volatile stock-based compensation add-backs, so the apparent conversion strength may overstate genuine earnings quality when net income itself is small or negative. The more telling signal is the direction of travel: OCF/NI of 14.62 in 2024Q2, 11.98 in 2025Q1, then -8.20 and 0.36 in the two most recent quarters, suggests the cushion that previously masked thin reported earnings is thinning. Investors should monitor whether operating cash flow converges toward the weak net income figures or rebounds with the seasonal fourth quarter.
Free Cash Flow Slides Below Half
Free cash flow across the last four quarters totaled $17.3M versus $30.7M in the prior four, and quarterly FCF margin slid from 21.8% in 2024Q4 to roughly break-even in 2026Q3, as reported in FC's filings, pointing to a sustained downward cash trajectory.
Two of the last five quarters posted negative free cash flow (2025Q2 at -$3.6M and 2026Q1 at -$1.6M), and the 2026Q3 result of -$32K effectively erased any cushion for shareholder returns. The pattern appears heavily seasonal, with 2024Q4 and 2025Q1 carrying the bulk of annual cash generation, but each successive seasonal peak has come off the prior level, consistent with the revenue plateau noted in the income statement work. If the current fiscal year fails to replicate the prior year's fourth-quarter cash harvest, full-year FCF could fall materially below the pace required to sustain the ongoing repurchase program.
Working Capital Swings Cloud Collections
Working capital swung from a $7.8M source in 2025Q1 to a $5.1M use in 2025Q2 and a $1.7M drag in 2026Q3, an uneven pattern that, per Franklin Covey's disclosures, contributes materially to quarterly OCF volatility rather than a steady cash conversion cycle.
Cumulative working capital contributed roughly $13.6M over the ten quarters, a meaningful share of the $89.3M of operating cash flow, which implies cash generation is partially dependent on balance sheet timing rather than purely on operating profitability. The negative prints in 2024Q3 (-$4.3M), 2025Q2 (-$5.1M), and 2026Q3 (-$1.7M) suggest that in quarters without the customary year-end collection benefit, receivables or payables movements absorb cash. With revenue trending lower, an analyst should watch whether payables extension or slower collections are increasingly supporting the operating cash line, though the aggregate disclosure does not permit decomposition.
Buybacks Outpace Cumulative Free Cash
Franklin Covey repurchased roughly $79.9M of stock over ten quarters while paying no dividends, outspending the $64.8M of cumulative free cash flow generated over the same window, and according to the company's cash flow statements, the $28.4M buyback in 2026Q2 alone exceeded that quarter's $13.2M of free cash flow.
The cumulative $15.1M shortfall between repurchases and free cash flow implies the buyback has been partially funded from balance sheet resources or financing, a pattern that becomes harder to sustain if the FCF trajectory identified above continues to weaken. Notably, repurchase activity accelerated to $28.4M in 2026Q2 even as the business posted a net loss, which could indicate a deliberate valuation-driven program but also raises questions about capital allocation discipline absent dividends as a stabilizing commitment. Given the lack of acquisition spending across all ten quarters, deployment appears concentrated in equity retirement, making FCF durability the single most important variable for sustaining it.
Reinvestment Shortfall Beneath Cash Strength
Stock-based compensation of about $18.6M over ten quarters nearly matches cumulative buybacks, and depreciation of roughly $2.1M per quarter regularly exceeds $1.0-1.7M of quarterly capex, raising, based on FC's reported figures, the possibility that reported cash generation flatters true reinvestment needs.
Capex ran below depreciation in nine of the ten quarters observed, with only 2025Q4 ($4.2M versus $2.4M of D&A) breaking the pattern, which may indicate deferred investment in technology or delivery infrastructure rather than structural capital efficiency. Combined with the equity-funded appearance of the buyback program, this raises the analytical question of whether cash available to shareholders is being overstated by under-replacement of assets. This remains an inference rather than a disclosed shortfall, and investors should test it against asset ages, software capitalization policy, and any future step-up in capital spending.